Cellsway
Nether Alderley
About Cellsway
Cellsway is a liquid biopsy company that was created to provide quick cancer CTC detection methods. The business's technology, which is minimally invasive and uses a straightforward blood sample for cancer monitoring, enables healthcare professionals to heal their patients and enhance their quality of life. focuses on the development of microfluidics and lab-on-a-chip technologies for biomedical purposes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $1.9M
- Funding stage: Seed
- Last round: Seed (Aug 2024)
- Website: cellsway.com
- Phone: +44 7778-061730
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/cellsway-65935 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.